Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2014/06/14 07:44:58」(JST)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. ゴーシェ病：病因、臨床症状、および診断 gaucher disease pathogenesis clinical manifestations and diagnosis
2. ゴーシェ病：治療 gaucher disease treatment
3. ゴーシェ病：初期評価、モニタリング、および臨床経過 gaucher disease initial assessment monitoring and clinical course
4. 肝生検標本の解釈 interpretation of liver biopsy specimens
5. 骨壊死症（無血管性骨壊死症） osteonecrosis avascular necrosis of bone

Comparative lipidomic study of urothelial cancer models: association with urothelial cancer cell invasiveness.

Yu Y1, Skočaj M2, Kreft ME3, Resnik N3, Veranič P3, Franceschi P4, Sepčić K5, Guella G6.
Molecular bioSystems.Mol Biosyst.2016 Aug 16. [Epub ahead of print]
Comparative lipidomic studies were performed across the RT4 versus T24 urothelial cancer cell lines, as models for noninvasive urothelial papilloma cells (with a relatively high level of differentiation) and invasive urothelial carcinoma cells (with low level of differentiation), respectively. The a
PMID 27527902

Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in Europe.

Belmatoug N1, Di Rocco M2, Fraga C3, Giraldo P4, Hughes D5, Lukina E6, Maison-Blanche P7, Merkel M8, Niederau C9, Plӧckinger U10, Richter J11, Stulnig TM12, Vom Dahl S13, Cox TM14.
European journal of internal medicine.Eur J Intern Med.2016 Aug 10. pii: S0953-6205(16)30217-5. doi: 10.1016/j.ejim.2016.07.011. [Epub ahead of print]
PURPOSE: In Gaucher disease, diminished activity of the lysosomal enzyme, acid β-glucosidase, leads to accumulation of glucosylceramides and related substrates, primarily in the spleen, liver, and bone marrow. Eliglustat is an oral substrate reduction therapy approved in the European Union and the
PMID 27522145

An LC/MS/MS method for the simultaneous determination of individual sphingolipid species in B cells.

Mi S1, Zhao YY1, Dielschneider RF2, Gibson SB2, Curtis JM3.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.J Chromatogr B Analyt Technol Biomed Life Sci.2016 Jul 16;1031:50-60. doi: 10.1016/j.jchromb.2016.07.028. [Epub ahead of print]
Comprehensive profiling of sphingolipids is of great importance for clinical and pharmaceutical studies. An LC/MS/MS method was established for the simultaneous separation and quantification of individual sphingolipid species including ceramides, dihydroceramides, glucosylceramides, sphingosine, sph
PMID 27450899

Isolation and Structure of a Galactocerebroside from the Sea Cucumber Bohadschia argus

Ikeda Yuriko,Inagaki Masanori,Yamada Koji [他],ZHANG Xiao Wen,ZHANG Bo,MIYAMOTO Tomofumi,HIGUCHI Ryuichi
Chemical & pharmaceutical bulletin 57(3), 315-317, 2009-03-01
… The parent cerebroside BAC-4 has been isolated from less polar lipid fraction of CHCl_3/MeOH extract of sea cucumber Bohadschia argus, together with known typical types of glucocerebroside molecular species. …
NAID 110007122349

糸乗前,鵜飼佑輝,井上多加志 [他],小島寿夫,齋藤洋昭,伊藤將弘,杉田睦海
滋賀大学教育学部紀要. 3, 自然科学 58, 13-20, 2008
… The purified cerebroside (6.5mg) was characterized to be a glucocerebroside by gas-liquid chromatography (GC), gas chromatograph-mass spectrometry (GC-MS), matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) and 1H-nuclear magnetic resonance spectroscopy (NMR). …
NAID 110007092951